Aug 2026· Journal of Pure and Applied Microbiology· Vol 20, pp. 2181· 0 citations
TL;DR
This integrated computational vaccinology approach reliably identifies promising antigenic targets for V. alginolyticus, providing a foundation for the rational development of next-generation polyvalent vaccines against Vibrio infections in aquaculture and related fields.
Abstract
Vibrio alginolyticus is an opportunistic marine pathogen that causes severe vibriosis in aquatic animals and occasionally in humans, leading to substantial economic losses in aquaculture. Despite progress in antimicrobial therapy, the emergence of multidrug-resistant (MDR) strains and the lack of effective vaccines have emphasized the need for novel approaches. The objective of this study was to identify and assess vaccine candidates in V. alginolyticus ATCC 17749 using an integrative strategy that integrates reverse vaccinology and immune-informatics. The complete proteome of V. alginolyticus ATCC 17749 was retrieved from NCBI databases, and computational pipelines were used to predict subcellular localization, transmembrane topology, and antigenicity. Surface-exposed, non-allergenic and non-toxic outer membrane and secretory proteins with high antigenicity scores were selected for epitope prediction. Cytotoxic T lymphocyte (CTL), helper T lymphocyte (HTL), and B-cell epitopes were identified through NetMHCpan 4.1, IEDB, and ABCpred, respectively. Robust humoral and cellular immune responses were predicted by immune simulation. The target proteins were docked with TLR2 and TLR4 using HDOCK, and the simulation was performed using the iMODS server for the highest-scoring docking complex for each receptor. In silico cloning to express the target protein was performed using the SnapGene tool. This integrated computational vaccinology approach reliably identifies promising antigenic targets for V. alginolyticus, providing a foundation for the rational development of next-generation polyvalent vaccines against Vibrio infections in aquaculture and related fields.
Through multi-omics integration analysis, this study successfully identified a novel candidate antigen, BMEI1943, with strong Th1-type immunogenicity, providing an experimental basis for the development of safe and efficient subunit vaccines against brucellosis.
Zhi-Heng Dong, Sha Li, Jiarong Guo et al.· Brazilian Journal of Microbi...· 0 citations
The rationally designed multi-epitope vaccine demonstrates robust theoretical potential to elicit comprehensive, long-lasting immunity in humans, although its safety and effectiveness require additional experimental validation.
Chenchen Yi, Yu Shen, Ye Luo et al.· Frontiers in Cellular and In...· 0 citations
Legionella pneumophila is a Gram-negative opportunistic pathogen responsible for Legionnaires’ disease, a severe form of atypical pneumonia associated with high morbidity and mortality, particularly in immunocompromised individuals. Despite its growing global burden and the persistence of environmental reservoirs, no l...
Lokesh Thangamani, Tong Lian· International Journal of Mol...· 0 citations
The development of a multi-epitope messenger RNA (mRNA) vaccine candidate targeting Brucella melitensis, the most pathogenic species responsible for human brucellosis is reported, establishing a promising platform for Brucella vaccine development warranting further evaluation in large animal models and human clinical t...
Zhi-Heng Dong, Sha Li, Jiarong Guo et al.· Research in Veterinary Scien...· 0 citations
This in-silico designed vaccine demonstrated strong structural stability, receptor interactions, and immunogenic potential against T. brucei and achieved 100% global population coverage.
Trichinella spiralis is a parasitic nematode causing trichinellosis, a significant zoonotic disease, and the development of an effective vaccine remains a crucial goal. This study employed a comprehensive computational approach to design a multi‑epitope mRNA vaccine against T. spiralis. From 49,084 T. spiralis proteins...
Roohollah Fattahi· Asia-Pacific Journal of Mole...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.